Delivery Order SPE2DB24D2010-SPE2DB25FAAWD
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ciprofloxacin HCL 250 mg tablets (100-count units) with a ceiling value of $1,069.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,822.55. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packaging) under a firm fixed price contract valued at $2,466.80. This delivery order, which was not set-aside, is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction for pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100 units, with a ceiling value of $1,403.89. This contract utilizes a firm fixed price model with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,756.82 on August 8, 2025, for the supply of Cipro 500 mg tablets (100 count). This non-competitive, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of ongoing pharmaceutical procurement needs for federal military...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cipro 500 mg tablets (100-count units) with a ceiling value of $1,175.85. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside procurement issued to the prime contractor at its Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAWDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and was competitively awarded through open procurement mechanisms. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle valued through December 2026. This prime contract enables AmerisourceBergen to serve as a critical supplier for military healthcare systems and the Defense Health Agency, delivering a wide range of pharmaceutical products, vaccines, and medical supplies globally. The ciprofloxacin order fulfills DLA's medical supply chain requirements for antibiotic distribution to support military and federal healthcare operations, demonstrating the company's ongoing role as a major vendor for federal pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/18/25 |